ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Enveric Biosciences Inc

Enveric Biosciences Inc (ENVB)

0.3081
-0.0418
( -11.95% )
Actualizado: 08:57:03

Su centro para precios en tiempo real, ideas y debates en vivo

Estadísticas y detalles clave

Último Precio
0.3081
Postura de Compra
0.3081
Postura de Venta
0.31
Volume Operado de la Acción
180,409
0.3051 Rango del Día 0.3249
0.3051 Rango de 52 semanas 2.92
Capitalización de Mercado [m]
Precio Anterior
0.3499
Precio de Apertura
0.3249
Última hora de negociación
08:56:46
Volumen financiero
US$ 57,073
Precio Promedio Ponderado
0.316353
Volumen promedio (3 m)
543,391
Acciones en circulación
8,919,920
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-0.18
Beneficio por acción (BPA)
-1.96
turnover
-
Beneficio neto
-17.46M

Acerca de Enveric Biosciences Inc

Enveric Biosciences Inc is a patient-centric biotechnology company focused on developing new-generation, naturally occurring chemical compounds, such as cannabinoids to improve the lives of those who are adversely affected by the side effects of cancer treatments. Its product in the pipeline include... Enveric Biosciences Inc is a patient-centric biotechnology company focused on developing new-generation, naturally occurring chemical compounds, such as cannabinoids to improve the lives of those who are adversely affected by the side effects of cancer treatments. Its product in the pipeline includes Glioblastoma Multiforme (GBM); Radiation Dermatitis and Chemotherapy-Induced Peripheral Neuropathy (CIPN). Mostrar más

Sector
Pharmaceutical Preparations
Industria
Pharmaceutical Preparations
Sitio web
Sede
Wilmington, Delaware, USA
Fundado
-
Enveric Biosciences Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ENVB. The last closing price for Enveric Biosciences was US$0.35. Over the last year, Enveric Biosciences shares have traded in a share price range of US$ 0.3051 to US$ 2.92.

Enveric Biosciences currently has 8,919,920 shares in issue. The market capitalisation of Enveric Biosciences is US$3.12 million. Enveric Biosciences has a price to earnings ratio (PE ratio) of -0.18.

ENVB Últimas noticias

Enveric Biosciences Reports Third Quarter 2024 Financial and Corporate Results

Advanced pre-IND activities and research for lead candidate, EB-003, a novel neuroplastogenic molecule designed to treat severe mental health disorders Announced the expansion of patent...

Enveric Biosciences Signs Out-Licensing Agreement with MycoMedica Life Sciences for EB-002

Agreement includes development and sales milestones payments potentially totaling up to $62 million as well as tiered single digit royalties on future sales Enveric Biosciences, Inc. (NASDAQ:...

Enveric Biosciences Announces Broad Range of Patent Issuances

New patents expand the number and type of compounds available for development and the possible indications targeted, increasing the potential value of Enveric’s drug candidate library Enveric...

Enveric Biosciences Announces Positive Pharmacology and Safety Data for Lead Product, EB-003

In vitro pharmacology studies confirmed EB-003’s ability to target desired serotonergic receptors, supporting the potential of the neuroplastogenic therapeutic candidate to address...

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1-0.092001-22.99444390290.4001010.43630.30511860850.36884414CS
4-0.2394-43.72602739730.54750.550.30512728720.44715967CS
12-0.2187-41.51480637810.52680.560.30515433910.4425818CS
26-0.5309-63.27771156140.8390.850.30518115430.52980076CS
52-1.1519-78.8972602741.462.920.305116109791.12571128CS
156-1.3419-81.32727272731.6514.870.155113897321.66625881CS
260-5.4919-94.68793103455.814.870.155118927642.46931905CS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
WORXSCWorx Corporation
US$ 2.365
(141.33%)
69M
SKKSKK Holdings Limited
US$ 10.19
(123.46%)
878.71k
SPAISafe Pro Group Inc
US$ 4.9802
(55.63%)
31.58M
CRNCCerence Inc
US$ 4.3696
(54.95%)
5.96M
CDTConduit Pharmaceuticals Inc
US$ 0.1305
(41.39%)
373.55M
PYXSPyxis Oncology Inc
US$ 2.045
(-46.47%)
6.01M
KURAKura Oncology Inc
US$ 9.995
(-37.18%)
4.37M
BLRXBioLineRx Ltd
US$ 0.36989
(-32.16%)
4.04M
SHOTWSafety Shot Inc
US$ 0.11
(-26.67%)
1,000
TMTCTMT Acquisition Corporation
US$ 4.73
(-26.55%)
7.92k
CDTConduit Pharmaceuticals Inc
US$ 0.1296
(40.41%)
373.85M
AKTSAkoustis Technologies Inc
US$ 0.0942
(8.15%)
155.39M
NVDANVIDIA Corporation
US$ 146.39
(0.34%)
109.81M
WORXSCWorx Corporation
US$ 2.3695
(141.79%)
69.02M
ELABElevai Labs Inc
US$ 0.0204
(-4.67%)
46.86M

ENVB Discussion

Ver más
TrendTrade2016 TrendTrade2016 1 mes hace
DILUTE INTO NEWS.....WELCOME TO THE SUB PENNY NASDAQ DILUTION PROGRAMS
👍️0
Awl416 Awl416 1 mes hace
Enveric Biosciences Announces Positive Pharmacology and Safety Data for Lead Product, EB-003
👍️0
glenn1919 glenn1919 4 meses hace
ENVB...........................https://stockcharts.com/h-sc/ui?s=ENVB&p=W&b=5&g=0&id=p86431144783
👍️0
Monksdream Monksdream 5 meses hace
ENVB new 52 week low
👍️0
Monksdream Monksdream 6 meses hace
Mighty fluffy press release
👍️0
Awl416 Awl416 6 meses hace
Enveric Biosciences Announces Signing of Non-Binding Term Sheet with Undisclosed Licensee for Exclusive License to Patented Methods of Treating Breast and Other Cancers Using Cannabinoids
👍️0
Awl416 Awl416 8 meses hace
Enveric Biosciences Signs Non-Binding Term Sheets to Pursue the Exclusive Out-Licensing of New Chemical Entities for Pharmaceutical and Non-Pharmaceutical Applications in Joint Disease
👍️0
Monksdream Monksdream 8 meses hace
ENVB under $2
👍️0
glenn1919 glenn1919 9 meses hace
ENVB.........................................https://stockcharts.com/h-sc/ui?s=ENVB&p=W&b=5&g=0&id=p86431144783
👍️0
Invest-in-America Invest-in-America 9 meses hace
ENVB: The Pro's are now workin' on their THIRD-NICE-FLIP behind this (easy money) puppy today!!! (I.e., one 100%-profit flip in the Pre-M, & now TWO circa 25-to-30%-profit flips in the Open-M!!! Yet STUPID traders cry about "Wash Trades". L.M.M.F.A.O.!!!!!)
👍️0
Invest-in-America Invest-in-America 9 meses hace
ENVB: Heck, "Wash-Trades" keep those PROFITS nice & CLEAN!!!!
👍️0
Monksdream Monksdream 9 meses hace
Wash trade du jour
👍️0
Invest-in-America Invest-in-America 9 meses hace
ENVB: I'm buyin' latte's for everyone later today, up on the MOON!!!
👍️0
Invest-in-America Invest-in-America 9 meses hace
ENVB: 3-bagger from here, whether anybody likes it or not!! (Just the way it goes, these days!!)
👍️0
TimeFades TimeFades 9 meses hace
Nasty trap
👍️0
TimeFades TimeFades 9 meses hace
Short
👍️0
tw0122 tw0122 9 meses hace
The term sheets further provide that, Enveric could be eligible to receive future development and sales milestone payments and execution fees for the three licenses, which in total could add up to $200 million, assuming certain conditions are met, including receiving approval for the investigational new drug (IND) applications and completing Phases I through III testing of the licensed products. Royalty rates on each of the three licenses could range from 2.5% up to 10% on future sales, depending on meeting certain sales criteria. The compound classes under the term sheets come from two of the seven portfolios of preclinical molecules that Enveric recently unveiled as available for out-licensing. Numerous molecules and classes remain available for additional out-licensing opportunities.

“Patients living with serious mental health conditions have seen insufficient innovation for far too long, and we are excited for the opportunity to progress several of the novel compounds generated using our drug discovery engine,” said Joseph Tucker, Ph.D., Director and CEO of Enveric. “We look forward to working with our partner, and we are confident in their leadership and capabilities to work on further developing these drug candidates to advance treatment options for patients. Ultimately, we believe the definitive licensing agreements, once negotiated and finalized, could represent an excellent potential source of revenue for Enveric, and could demonstrate the value creation from Enveric’s discovery capabilities and proprietary PsyAI™ and Psybrary™ platforms, which have already generated an impressive library of compounds targeting a variety of CNS disorders.”
👍️0
glenn1919 glenn1919 9 meses hace
ENVB.........................................https://stockcharts.com/h-sc/ui?s=ENVB&p=W&b=5&g=0&id=p86431144783
👍️0
Awl416 Awl416 9 meses hace
Enveric Biosciences Agrees to Sell Cancer-Targeting Cannabinoid-Related Intellectual Property
👍️0
I-Glow I-Glow 1 año hace
What's the patent application number?

IG
👍️0
Awl416 Awl416 1 año hace
4.96 to 3 blink of any eye
👍️0
Triple nickle Triple nickle 1 año hace
7.52 easy
👍️0
Jess070283 Jess070283 1 año hace
$4-$5.75. Done for the day. Wooo
👍️0
Awl416 Awl416 1 año hace
Enveric Biosciences Receives Notice of Allowance From USPTO for C4-Carboxylic Acid-Substituted Tryptamine Derivatives for Next Generation Psilocin Prodrug
👍️0
PennyPusher786 PennyPusher786 2 años hace
Nice flipper
👍️0
Triple nickle Triple nickle 2 años hace
Ok it cooled off
Five dollar run
👍️0
PennyPusher786 PennyPusher786 2 años hace
Now a Rug Pooool candidate lol... Now it's too dangerous... It can run 4+ but it can dump too as seen from 4.20s to 3.20s in all of 15 seconds
👍️0
PennyPusher786 PennyPusher786 2 años hace
Another rip or another dump, only the devil knows
👍️0
PennyPusher786 PennyPusher786 2 años hace
Good call. Ran to 4.20s and dumped to 3.20s
👍️0
Triple nickle Triple nickle 2 años hace
I’m out
👍️0
surf1944 surf1944 2 años hace
https://stockcharts.com/h-sc/ui?s=envb&p=D&yr=0&mn=6&dy=0&id=p38090673899

https://www.barchart.com/stocks/quotes/envb/technical-chart?plot=CANDLE&volume=total&data=DO&density=ML&pricesOn=1&asPctChange=0&logscale=0&indicators=ACCUM;SMA(20);SMA(50);SMA(100);SMA(200);CHKMF(20)&sym=SYSX&grid=1&height=210&studyheight=100

https://www.barchart.com/stocks/quotes/envb/opinion

Open gap at $1.52
👍️0
PennyPusher786 PennyPusher786 2 años hace
There's another pullback
👍️0
Invest-in-America Invest-in-America 2 años hace
Ooooooops!! (iHub posting error, glitch, etc.).
👍️0
Invest-in-America Invest-in-America 2 años hace
ENVB: I'm workin' on an ANSWER to your question right now, Sir. (See my 'Chart' on this, below.)

👍️0
TheFinalCD TheFinalCD 2 años hace
WALL @ 3.50 JUST TAKEN OUT
👍️0
PennyPusher786 PennyPusher786 2 años hace
Anyone smell a bait and pull? Lol or do we forsee $5- 6
👍️0
Invest-in-America Invest-in-America 2 años hace
ENVB: See ya-all up on the MOON later, Folks!!
👍️0
PennyPusher786 PennyPusher786 2 años hace
Same. I expect pullbacks and runs if the volume stays consistent.. which means mass flipping
👍️0
Triple nickle Triple nickle 2 años hace
Watching
👍️0
PennyPusher786 PennyPusher786 2 años hace
This could run 5 - 6 today.
👍️0
Triple nickle Triple nickle 2 años hace
Sell down now
👍️0
Awl416 Awl416 2 años hace
Enveric Biosciences Receives Notice of Allowance from USPTO for Novel Prodrug of Psilocin
👍️0
DDA DDA 2 años hace
The RS already took place. Don't understand why my post would need to ve deleted
👍️0
Klinsmann Klinsmann 2 años hace
But gonna be a nice entry soon imo
👍️0
Roadtojourney Roadtojourney 2 años hace
Rs and dilution followed right after wow??
👍️0
DDA DDA 2 años hace
Reverse split just anounced
👍️0
BoilerRoom BoilerRoom 2 años hace
What are other biotech stocks I’m not familiar with this sector. Appreciate your feedback MASTERULTRA you seem to know about these.
👍️0
MASTERULTRA MASTERULTRA 3 años hace
Seriously, WTF!!! this company should be trending higher due to 04/20...

I fucking hope the people who short this or manipulate this gets Karma.
👍️0
DallasInvest DallasInvest 3 años hace
The douche canoe Dj front load of the day lol
👍️0
TommyBoyTrader9460 TommyBoyTrader9460 3 años hace
$ENVB Added..looks like interest building here..
👍️0